Evidence map›Paper›PMID 33800090›Full record

ArticleViruses2021

Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.

Yasmin A Parr, Melissa J Beall, Julie K Levy, Michael McDonald, Natascha T Hamman, Brian J Willett, Margaret J Hosie

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yasmin A ParrMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.ORCID 0000-0002-4658-6698
Melissa J BeallIDEXX Laboratories, Inc.-Westbrook, ME 04092, USA.
Julie K LevyMaddie's Shelter Medicine Program, University of Florida, Gainesville, FL 32608, USA.ORCID 0000-0002-4849-288X
Michael McDonaldVeterinary Diagnostic Services, University of Glasgow, Glasgow, Scotland G61 1QH, UK.
Natascha T HammanAustin Pets Alive!, Austin, TX 78703, USA.
Brian J WillettMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.ORCID 0000-0001-8912-3266
Margaret J HosieMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland G61 1QH, UK.ORCID 0000-0002-4313-5023
MRC University of Glasgow Centre for Virus Research · GBIDEXX Laboratories (United States) · USUniversity of Florida · USUniversity of Glasgow · GB

Funding

Medical Research Council MC_UU_12014/10
6 · The paper itself

Abstract

Retroviruses belong to an important and diverse family of RNA viruses capable of causing neoplastic disease in their hosts. Feline leukaemia virus (FeLV) is a gammaretrovirus that infects domestic and wild cats, causing immunodeficiency, cytopenia and neoplasia in progressively infected cats. The outcome of FeLV infection is influenced by the host immune response; progressively infected cats demonstrate weaker immune responses compared to regressively infected cats. In this study, humoral immune responses were examined in 180 samples collected from 123 domestic cats that had been naturally exposed to FeLV, using a novel ELISA to measure antibodies recognizing the FeLV surface unit (SU) glycoprotein in plasma samples. A correlation was demonstrated between the strength of the humoral immune response to the SU protein and the outcome of exposure. Cats with regressive infection demonstrated higher antibody responses to the SU protein compared to cats belonging to other outcome groups, and samples from cats with regressive infection contained virus neutralising antibodies. These results demonstrate that an ELISA that assesses the humoral response to FeLV SU complements the use of viral diagnostic tests to define the outcome of exposure to FeLV. Together these tests could allow the rapid identification of regressively infected cats that are unlikely to develop FeLV-related disease.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralCapsid ProteinsCatsEnzyme-Linked Immunosorbent AssayImmunity, HumoralLeukemia, FelineLeukemia Virus, FelineProvirusesTumor Virus InfectionsViral LoadViral ProteinsAntibodies, NeutralizingAntibodies, ViralCapsid ProteinsViral Proteinsdiagnosticsexposure outcomesFeLVhumoral immune responseretrovirusSU antibody response

Identifiers

PMID33800090
PMCPMC7998633
OpenAlexW3135295064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.